Confluence Pharmaceuticals
  • Home
  • About Us
  • Pipeline
  • News
  • Contact Us

Restoring Hope, Unlocking Potential

Confluence's mission is to advance all research in Autism and Fragile X Syndrome and bring to market a solution that treats core social and communication impairments.  We understand the profound impact of being able to communicate and socially interact has on everyday life.  We want to change the way people think about treating Fragile X and Autism....and how they will administer or direct therapies in the future.




What We Do

Confluence is developing a novel, clinically-discovered therapeutic treatment for core social and communication impairments caused by Fragile X Syndrome and Autism Spectrum Disorders. We are targeting important functionality - talking, thinking, social interaction, and self-care. 


Powered by Create your own unique website with customizable templates.